September 7, 2006
VelociGene technology selected for the NIH Knockout Mouse Project (KOMP)

More News | Publications

Regeneron Will Use its VelociGene® Technology to Target Genes, Providing New Models of Human Disease.

Data Access

Fastest from concept to Knockout mice without sacrificing precision and complexity.

Learn about our services

VelociGene allows scientists to rapidly identify the physical and biological effects of deleting or over-expressing the target gene. View Slideshow